Back to Search Start Over

In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli .

Authors :
Karlowsky JA
Adam HJ
Baxter MR
Denisuik AJ
Lagacé-Wiens PRS
Walkty AJ
Puttagunta S
Dunne MW
Zhanel GG
Source :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2018 Dec 21; Vol. 63 (1). Date of Electronic Publication: 2018 Dec 21 (Print Publication: 2019).
Publication Year :
2018

Abstract

The in vitro activity of sulopenem was assessed against a collection from 2014 to 2016 of 539 urinary isolates of Escherichia coli from Canadian patients by using CLSI-defined broth microdilution methodology. A concentration of sulopenem 0.03 µg/ml inhibited both 50% (MIC <subscript>50</subscript> ) and 90% (MIC <subscript>90</subscript> ) of isolates tested; sulopenem MICs ranged from 0.015 to 0.25 µg/ml. The in vitro activity of sulopenem was unaffected by nonsusceptibility to trimethoprim-sulfamethoxazole and/or ciprofloxacin, multidrug-resistant phenotypes, extended-spectrum β-lactamases, or AmpC β-lactamases.<br /> (Copyright © 2018 American Society for Microbiology.)

Details

Language :
English
ISSN :
1098-6596
Volume :
63
Issue :
1
Database :
MEDLINE
Journal :
Antimicrobial agents and chemotherapy
Publication Type :
Academic Journal
Accession number :
30397056
Full Text :
https://doi.org/10.1128/AAC.01832-18